Figure 2.
Cumulative number of preventable site-specific obesity-related cancers for females and males through the use of GLP-1 receptor agonists in Canada between 2031 and 2049.
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.